학술논문

Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial
Document Type
Article
Source
In: Nature Medicine. (Nature Medicine, November 2022, 28(11):2374-2380)
Subject
Language
English
ISSN
1546170X
10788956